Literature DB >> 21644516

Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma.

Danielle Rand1, Vivian Ortiz, Yanan Liu, Zoltan Derdak, Jack R Wands, Milan Tatíček, Christoph Rose-Petruck.   

Abstract

We present the development of a new imaging technique for the early diagnosis of hepatocellular carcinoma that utilizes surface-modified gold nanoparticles in combination with X-ray imaging. Tissues labeled with these electron-dense particles show enhanced X-ray scattering over normal tissues, distinguishing cells containing gold nanoparticles from cells without gold in X-ray scatter images. Our results suggest that this novel approach could enable the in vivo detection of tumors as small as a few millimeters in size.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21644516      PMCID: PMC3138192          DOI: 10.1021/nl200858y

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  30 in total

Review 1.  Recent advances in imaging hepatocellular carcinoma: diagnosis, staging and response assessment: functional imaging.

Authors:  S F Hain; I Fogelman
Journal:  Cancer J       Date:  2004 Mar-Apr       Impact factor: 3.360

2.  Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study.

Authors:  J C Sheu; J L Sung; D S Chen; M Y Lai; T H Wang; J Y Yu; P M Yang; C N Chuang; P C Yang; C S Lee
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

Review 3.  Antibody-directed therapy for human hepatocellular carcinoma.

Authors:  Leonhard Mohr; Andy Yeung; Costica Aloman; Dane Wittrup; Jack R Wands
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  The use of gold nanoparticles to enhance radiotherapy in mice.

Authors:  James F Hainfeld; Daniel N Slatkin; Henry M Smilowitz
Journal:  Phys Med Biol       Date:  2004-09-21       Impact factor: 3.609

Review 5.  Hepatocellular carcinoma.

Authors:  K Okuda
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

6.  Radioimmunolocation of hepatic and pulmonary metastasis of human colon adenocarcinoma.

Authors:  H Takahashi; R Carlson; M Ozturk; S Sun; P Motte; W Strauss; K J Isselbacher; J R Wands; D Shouval
Journal:  Gastroenterology       Date:  1989-05       Impact factor: 22.682

7.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance.

Authors:  L R Hirsch; R J Stafford; J A Bankson; S R Sershen; B Rivera; R E Price; J D Hazle; N J Halas; J L West
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

8.  Establishment and characterization of a new human hepatocellular carcinoma cell line.

Authors:  L He; K J Isselbacher; J R Wands; H M Goodman; C Shih; A Quaroni
Journal:  In Vitro       Date:  1984-06

Review 9.  Hepatocellular carcinoma: paradigm of preventive oncology.

Authors:  Thomas R O'Brien; Gregory Kirk; Mingdong Zhang
Journal:  Cancer J       Date:  2004 Mar-Apr       Impact factor: 3.360

10.  Rational design of cytophilic and cytophobic polyelectrolyte multilayer thin films.

Authors:  Jonas D Mendelsohn; Sung Yun Yang; Jeri'Ann Hiller; Allon I Hochbaum; Michael F Rubner
Journal:  Biomacromolecules       Date:  2003 Jan-Feb       Impact factor: 6.988

View more
  14 in total

1.  X-ray spatial frequency heterodyne imaging of protein-based nanobubble contrast agents.

Authors:  Danielle Rand; Masaki Uchida; Trevor Douglas; Christoph Rose-Petruck
Journal:  Opt Express       Date:  2014-09-22       Impact factor: 3.894

2.  A highly sensitive x-ray imaging modality for hepatocellular carcinoma detection in vitro.

Authors:  Danielle Rand; Edward G Walsh; Zoltan Derdak; Jack R Wands; Christoph Rose-Petruck
Journal:  Phys Med Biol       Date:  2015-01-05       Impact factor: 3.609

3.  Motionless electromagnetic phase stepping versus mechanical phase stepping in x-ray phase-contrast imaging with a compact source.

Authors:  Katherine J Harmon; Houxun Miao; Andrew A Gomella; Eric E Bennett; Barbara A Foster; Priya Bhandarkar; Han Wen
Journal:  Phys Med Biol       Date:  2015-03-24       Impact factor: 3.609

4.  'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities.

Authors:  Hongwei Chen; Hayley Paholak; Masayuki Ito; Kanokwan Sansanaphongpricha; Wei Qian; Yong Che; Duxin Sun
Journal:  Nanotechnology       Date:  2013-08-12       Impact factor: 3.874

5.  Using X-ray in-line phase-contrast imaging for the investigation of nude mouse hepatic tumors.

Authors:  Qiang Tao; Dongyue Li; Lu Zhang; Shuqian Luo
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

6.  X-ray Scatter Imaging of Hepatocellular Carcinoma in a Mouse Model Using Nanoparticle Contrast Agents.

Authors:  Danielle Rand; Zoltan Derdak; Rolf Carlson; Jack R Wands; Christoph Rose-Petruck
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

7.  Selective killing of cancer cells by nanoparticle-assisted ultrasound.

Authors:  Olga K Kosheleva; Tsung-Ching Lai; Nelson G Chen; Michael Hsiao; Chung-Hsuan Chen
Journal:  J Nanobiotechnology       Date:  2016-06-14       Impact factor: 10.435

8.  Polyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis.

Authors:  Yinghua Li; Min Guo; Zhengfang Lin; Mingqi Zhao; Misi Xiao; Changbing Wang; Tiantian Xu; Tianfeng Chen; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2016-12-08

9.  Benefits and risks of the hormetic effects of dietary isothiocyanates on cancer prevention.

Authors:  Yongping Bao; Wei Wang; Zhigang Zhou; Changhao Sun
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

10.  Silver Nanoparticles Induce HePG-2 Cells Apoptosis Through ROS-Mediated Signaling Pathways.

Authors:  Bing Zhu; Yinghua Li; Zhengfang Lin; Mingqi Zhao; Tiantian Xu; Changbing Wang; Ning Deng
Journal:  Nanoscale Res Lett       Date:  2016-04-14       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.